| The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis S Gelperina, K Kisich, MD Iseman, L Heifets American journal of respiratory and critical care medicine 172 (12), 1487-1490, 2005 | 908 | 2005 |
| Transport of drugs across the blood–brain barrier by nanoparticles S Wohlfart, S Gelperina, J Kreuter Journal of controlled release 161 (2), 264-273, 2012 | 814 | 2012 |
| Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles AE Gulyaev, SE Gelperina, IN Skidan, AS Antropov, GY Kivman, J Kreuter Pharmaceutical research 16, 1564-1569, 1999 | 741 | 1999 |
| Direct evidence that polysorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the … J Kreuter, P Ramge, V Petrov, S Hamm, SE Gelperina, B Engelhardt, ... Pharmaceutical research 20, 409-416, 2003 | 638 | 2003 |
| Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles SCJ Steiniger, J Kreuter, AS Khalansky, IN Skidan, AI Bobruskin, ... International Journal of Cancer 109 (5), 759-767, 2004 | 595 | 2004 |
| Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly (butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants B Petri, A Bootz, A Khalansky, T Hekmatara, R Müller, R Uhl, J Kreuter, ... Journal of Controlled Release 117 (1), 51-58, 2007 | 426 | 2007 |
| Drug delivery to the brain using surfactant-coated poly (lactide-co-glycolide) nanoparticles: influence of the formulation parameters S Gelperina, O Maksimenko, A Khalansky, L Vanchugova, E Shipulo, ... European Journal of Pharmaceutics and Biopharmaceutics 74 (2), 157-163, 2010 | 357 | 2010 |
| Covalent attachment of apolipoprotein AI and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain J Kreuter, T Hekmatara, S Dreis, T Vogel, S Gelperina, K Langer Journal of controlled release 118 (1), 54-58, 2007 | 339 | 2007 |
| Brain targeting of nerve growth factor using poly (butyl cyanoacrylate) nanoparticles KB Kurakhmaeva, IA Djindjikhashvili, VE Petrov, VU Balabanyan, ... Journal of drug targeting 17 (8), 564-574, 2009 | 264 | 2009 |
| Toxicological studies of doxorubicin bound to polysorbate 80-coated poly (butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma SE Gelperina, AS Khalansky, IN Skidan, ZS Smirnova, AI Bobruskin, ... Toxicology letters 126 (2), 131-141, 2002 | 253 | 2002 |
| Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers S Wohlfart, AS Khalansky, S Gelperina, O Maksimenko, C Bernreuther, ... PloS one 6 (5), e19121, 2011 | 219 | 2011 |
| Use of nanoparticles for cerebral cancer J Kreuter, S Gelperina Tumori journal 94 (2), 271-277, 2008 | 199 | 2008 |
| Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly (butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats A Ambruosi, AS Khalansky, H Yamamoto, SE Gelperina, DJ Begley, ... Journal of drug targeting 14 (2), 97-105, 2006 | 167 | 2006 |
| Encapsulation of moxifloxacin within poly (butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis KO Kisich, S Gelperina, MP Higgins, S Wilson, E Shipulo, E Oganesyan, ... International Journal of Pharmaceutics 345 (1-2), 154-162, 2007 | 166 | 2007 |
| Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells Y Malinovskaya, P Melnikov, V Baklaushev, A Gabashvili, N Osipova, ... International journal of pharmaceutics 524 (1-2), 77-90, 2017 | 163 | 2017 |
| Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly (butyl cyanoacrylate) nanoparticles in a rat glioma model A Ambruosi, S Gelperina, A Khalansky, S Tanski, A Theisen, J Kreuter Journal of microencapsulation 23 (5), 582-592, 2006 | 133 | 2006 |
| Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier S Wohlfart, AS Khalansky, S Gelperina, D Begley, J Kreuter Journal of controlled release 154 (1), 103-107, 2011 | 127 | 2011 |
| Adsorption of plasma proteins on uncoated PLGA nanoparticles K Sempf, T Arrey, S Gelperina, T Schorge, B Meyer, M Karas, J Kreuter European Journal of Pharmaceutics and Biopharmaceutics 85 (1), 53-60, 2013 | 101 | 2013 |
| Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development O Maksimenko, J Malinovskaya, E Shipulo, N Osipova, V Razzhivina, ... International journal of pharmaceutics 572, 118733, 2019 | 100 | 2019 |
| Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio-and testicular toxicity E Pereverzeva, I Treschalin, D Bodyagin, O Maksimenko, K Langer, ... International journal of pharmaceutics 337 (1-2), 346-356, 2007 | 92 | 2007 |
Glatzel, MProfessor of Neuropathology Institute of Neuropathology, University Medical Center Hamburg-EppendorfVerified email at uke.de
